These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
650 related articles for article (PubMed ID: 32733816)
1. Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy. Mercer DK; Torres MDT; Duay SS; Lovie E; Simpson L; von Köckritz-Blickwede M; de la Fuente-Nunez C; O'Neil DA; Angeles-Boza AM Front Cell Infect Microbiol; 2020; 10():326. PubMed ID: 32733816 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists. Wenzler E; Maximos M; Asempa TE; Biehle L; Schuetz AN; Hirsch EB Pharmacotherapy; 2023 Apr; 43(4):264-278. PubMed ID: 36825480 [TBL] [Abstract][Full Text] [Related]
3. The Role of Antimicrobial Peptides as Antimicrobial and Antibiofilm Agents in Tackling the Silent Pandemic of Antimicrobial Resistance. Lopes BS; Hanafiah A; Nachimuthu R; Muthupandian S; Md Nesran ZN; Patil S Molecules; 2022 May; 27(9):. PubMed ID: 35566343 [TBL] [Abstract][Full Text] [Related]
4. Reasons for antimicrobial treatment failures and predictive value of in-vitro susceptibility testing in veterinary practice: An overview. Richter A; Feßler AT; Böttner A; Köper LM; Wallmann J; Schwarz S Vet Microbiol; 2020 Jun; 245():108694. PubMed ID: 32456814 [TBL] [Abstract][Full Text] [Related]
5. Rapid antimicrobial susceptibility tests for sepsis; the road ahead. Inglis TJJ; Ekelund O J Med Microbiol; 2019 Jul; 68(7):973-977. PubMed ID: 31145055 [TBL] [Abstract][Full Text] [Related]
6. Modern Tools for Rapid Diagnostics of Antimicrobial Resistance. Vasala A; Hytönen VP; Laitinen OH Front Cell Infect Microbiol; 2020; 10():308. PubMed ID: 32760676 [TBL] [Abstract][Full Text] [Related]
7. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data. Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531 [TBL] [Abstract][Full Text] [Related]
8. Re-evaluation of FDA-approved antibiotics with increased diagnostic accuracy for assessment of antimicrobial resistance. Heithoff DM; Barnes V L; Mahan SP; Fried JC; Fitzgibbons LN; House JK; Mahan MJ Cell Rep Med; 2023 May; 4(5):101023. PubMed ID: 37116500 [TBL] [Abstract][Full Text] [Related]
10. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972 [TBL] [Abstract][Full Text] [Related]
11. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung. Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970 [TBL] [Abstract][Full Text] [Related]
13. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Smith S; Waters V; Jahnke N; Ratjen F Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436 [TBL] [Abstract][Full Text] [Related]
14. Novel Clinical mNGS-Based Machine Learning Model for Rapid Antimicrobial Susceptibility Testing of Acinetobacter baumannii. Hu X; Zhao Y; Han P; Liu S; Liu W; Mai C; Deng Q; Ren J; Luo J; Chen F; Jia X; Zhang J; Rao G; Gu B J Clin Microbiol; 2023 May; 61(5):e0180522. PubMed ID: 37022167 [TBL] [Abstract][Full Text] [Related]
15. Current concepts in laboratory testing to guide antimicrobial therapy. Jenkins SG; Schuetz AN Mayo Clin Proc; 2012 Mar; 87(3):290-308. PubMed ID: 22386185 [TBL] [Abstract][Full Text] [Related]
16. Phytotherapy as an alternative to conventional antimicrobials: combating microbial resistance. Enioutina EY; Teng L; Fateeva TV; Brown JCS; Job KM; Bortnikova VV; Krepkova LV; Gubarev MI; Sherwin CMT Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1203-1214. PubMed ID: 28836870 [TBL] [Abstract][Full Text] [Related]
17. Van Moll L; De Smet J; Paas A; Tegtmeier D; Vilcinskas A; Cos P; Van Campenhout L Microbiol Spectr; 2022 Feb; 10(1):e0166421. PubMed ID: 34985302 [TBL] [Abstract][Full Text] [Related]
18. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277 [TBL] [Abstract][Full Text] [Related]